CLINICAL THERAPEUTICS, vol.24, no.8, pp.1309-1321, 2002 (SCI-Expanded)
Background Olopatadine hydrochloride 0.1% eye drops represent a new class of anti-allergic agent with combined antihistaminic and mast cell-stabilizing properties.